Giuseppe Lucariello

Dr. Giuseppe Lucariello

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 April 2021 in Cancers
Verified
Journal Article
Open access
PDF file
Ester PaganoEster Pagano
Ester Pagano
TVTommaso Venneri
Tommaso Venneri
GLGiuseppe Lucariello
Giuseppe Lucariello
DCDonatella Cicia
Donatella Cicia
Vincenzo BrancaleoneVincenzo Brancaleone
Vincenzo Brancaleone
BRBarbara Romano
Barbara Romano
Palmitoylethanolamide (PEA) is an endogenous fatty acid amide related to the endocannabinoid anandamide. PEA exerts intestinal anti-inflammatory effects, but knowledge of its role in colon carcinogenesis is still largely fragmentary. We deepened this aspect by studying the effects of PEA (ultramicronized PEA, um-PEA) on colon cancer cell proliferation, migration and cell cycle as well as its effects in a murine model of colon cancer. Results showed that um-PEA inhibited tumor cell proliferation via peroxisome proliferator-activated receptor α and G protein-coupled receptor 55, induced cell cycle arrest in the G2/M phase, possibly through cyclin B1/CDK1 upregulation, and induced DNA fragmentation. Furthermore, um-PEA reduced tumor cell migration by reducing MMP2 and TIMP1 expression. In vivo administration of um-PEA exerted beneficial effects in the azoxymethane model of colonic tumors, by reducing the number of preneoplastic lesions and tumors. Collectively, our findings provide novel proofs on the effects of um-PEA in colon carcinogenesis.

14 January 2021 in Biomolecules
Verified
Journal Article
Open access
PDF file
BRBarbara Romano
Barbara Romano
GLGiuseppe Lucariello
Giuseppe Lucariello
Raffaele CapassoRaffaele Capasso
Raffaele Capasso
The use of remedies based on medicinal plants continues to expand rapidly around the world, with many people now resorting to this type of product for the treatment and prevention of several pathologies

28 December 2021 in British Journal of Pharmacology
Verified
Journal Article
Open access
PDF file
BRBarbara Romano
Barbara Romano
Ester PaganoEster Pagano
Ester Pagano
Fabio Arturo IannottiFabio Arturo Iannotti
Fabio Arturo Iannotti
Fabiana PiscitelliFabiana Piscitelli
Fabiana Piscitelli
Vincenzo BrancaleoneVincenzo Brancaleone
Vincenzo Brancaleone
AIAngelo A. Izzo
Angelo A. Izzo
Background and Purpose: N‐Acylethanolamine acid amidase (NAAA) is a lysosomal enzyme accountable for the breakdown of N‐acylethanolamines (NAEs) and its pharmacological inhibition has beneficial effects in inflammatory conditions. The knowledge of NAAA in cancer is fragmentary with an unclarified mechanism, whereas its contribution to colorectal cancer (CRC) is unknown to date.Experimental Approach: CRC xenograft and azoxymethane models were used to assess the in vivo effect of NAAA inhibition. Further, the tumour secretome was evaluated by an oncogenic array, CRC cell lines were used for in vitro studies, cell cycle was analysed by cytofluorimetry, NAAA was knocked down with siRNA, human biopsies were obtained from surgically resected CRC patients, gene expression was measured by RT‐PCR and NAEs were measured by LC–MS.Key Results: The NAAA inhibitor AM9053 reduced CRC xenograft tumour growth and counteracted tumour development in the azoxymethane model. NAAA inhibition affected the composition of the tumour secretome inhibiting the expression of EGF family members. In CRC cells, AM9053 reduced proliferation with a mechanism mediated by PPAR‐α and TRPV1. AM9053 induced cell cycle arrest in the S phase associated with cyclin A2/CDK2 down‐regulation. NAAA knock‐down mirrored the effects of NAAA inhibition with AM9053. NAAA expression was down‐regulated in human CRC tissues, with a consequential augmentation of NAE levels and dysregulation of some of their targets.Conclusion and Implications: Our results show novel data on the functional importance of NAAA in CRC progression and the mechanism involved. We propose that this enzyme is a valid drug target for the treatment of CRC growth and development.

18 May 2021 in Plants
Verified
Journal Article
Open access
PDF file
CSCarmina Sirignano
Carmina Sirignano
PNPascal Nadembega
Pascal Nadembega
FPFERRUCCIO POLI
FERRUCCIO POLI
BRBarbara Romano
Barbara Romano
GLGiuseppe Lucariello
Giuseppe Lucariello
Orazio Taglialatela-ScafatiOrazio Taglialatela-Scafati
Orazio Taglialatela-Scafati
Vitellaria paradoxa C. F. Gaertn is widely used in African traditional medicine as an anti-inflammatory remedy to treat rheumatism, gastric problems, diarrhea, and dysentery. The phytochemical investigation of the ethyl acetate extract of V. paradoxa stem bark collected in Burkina Faso led to the isolation of eight known and two triterpenes undescribed to date (7 and 10), in the free alcohol form or as acetyl and cinnamyl ester derivatives. The stereostructures of the new compounds were elucidated using HR-ESIMS and 1D and 2D NMR data. The isolated compounds were evaluated in vitro for their inhibitory effect on nitrite levels on murine macrophages J774 stimulated with the lipopolysaccharide (LPS). Among all the compounds tested, lupeol cinnamate (3) and betulinic acid (5) showed a beneficial effect in reducing nitrite levels produced after LPS stimulation.

19 March 2021 in Biomedicines
Verified
Journal Article
Open access
PDF file
GLGiuseppe Lucariello
Giuseppe Lucariello
DCDonatella Cicia
Donatella Cicia
Raffaele CapassoRaffaele Capasso
Raffaele Capasso
For years, plant-based remedies have been used as a traditional practice to treat and prevent a broad range of diseases